Pre-treatment gut microbiome and salivary metabolome signatures associate with chemotherapy-induced cognitive decline in women with breast cancer: A prospective pilot study. - Cross CB; Bowen JM; Leifert WR; Beale DJ; Francois M; Joshi R; Fosh BG; Coller JK; Tuke J; Bareham M; Cosier DJ; To LH; et al. (Cancer letters, 2026)